Development of a Three-Component Iron-Catalyzed Difluoromethylation Reaction
About This Grant
Project Summary/Abstract The incorporation of difluoromethyl (–CF2H) group has become a leading strategy in pharmaceutical development to enhance drug performance due to –CF2H’s unique and profound bioisosteric activity for hydroxyls, amines, and thiols as a result of its hydrogen bond ability. Presently, transition metal-mediated approaches for the direct incorporation of the –CF2H group is an attractive methodology in the context of selective late-stage functionalization of complex molecules. While there is an abundance of synthetic methods employing this approach for the formation of the traditional carbon(sp2)-CF2H bonds, general protocols for the formation of more challenging carbon(sp3)-CF2H bonds are still limited. Hence, there is an urgent and unmet need to develop new, sustainable, and efficient synthesis methods to accelerate the synthesis and evaluation of bioactive compounds containing C(sp3)-CF2H bonds. The hallmark of this proposal is the development of three-component iron-catalyzed difluoromethylation reactions mediated through iron metal for the formation of C(sp3)–CF2H bonds. To achieve this objective, I will put forward two strategies. The strategies differ not in the specific C(sp3)–CF2H bond that is to be formed, but in the distinct, yet complementary, mechanistic manifold of introducing the difluoromethyl group into the organic substrate. The first approach employs HCF2–X electrophiles as •CF2H radical precursors which can, through strategic manipulation of reaction conditions, engage with a “radical lynchpin” and subsequently C(sp3)–CF2H bond formation with a well-defined iron-species (Aim 1). The second strategy will implement the use of organozinc reagent, [(DMPU)2Zn(CF2H)2], as a nucleophilic source of –CF2H group to be transmetalated into the iron catalytic cycle as a complementary route to synthesize the C(sp3)–CF2H bond (Aim 2). To bolster these efforts, I plan to implement advanced spectroscopic techniques (Mössbauer spectroscopy and single-crystal X- ray diffraction) as well as computational chemistry to accelerate the development of three-component iron- catalyzed difluoromethylation reactions. While both approaches target the development of iron-mediated synthetic methods that permit the direct incorporation of the –CF2H group, the mode of introduction is different. In doing so, this research project will foster the growth in knowledge in iron catalysis. The long-term goal of this proposal is to expand the fundamental research of domestically manufactured metals in the U.S., such as earth-abundant iron, for the development of synthetic methods that permit expedient access to high-value molecules in an economical, sustainable, and safe manner all while fostering and refining our knowledge and understanding of it.
Grant Summary
Development of a Three-Component Iron-Catalyzed Difluoromethylation Reaction is a NIGMS - National Institute of General Medical Sciences grant providing up to $76K for university, nonprofit, healthcare org. Applications are due 2029-05-31 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $76K
2029-05-31
- 1Confirm your organization is eligible for Development of a Three-Component Iron-Catalyzed Difluoromethylation Reaction from NIGMS - National Institute of General Medical Sciences, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIGMS - National Institute of General Medical Sciences before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIGMS - National Institute of General Medical Sciences's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Development of a Three-Component Iron-Catalyzed Difluoromethylation Reaction: Frequently Asked Questions
Who is eligible for the Development of a Three-Component Iron-Catalyzed Difluoromethylation Reaction?
Development of a Three-Component Iron-Catalyzed Difluoromethylation Reaction is offered by NIGMS - National Institute of General Medical Sciences and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Development of a Three-Component Iron-Catalyzed Difluoromethylation Reaction provide?
Development of a Three-Component Iron-Catalyzed Difluoromethylation Reaction provides up to $76K per award from NIGMS - National Institute of General Medical Sciences. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Development of a Three-Component Iron-Catalyzed Difluoromethylation Reaction deadline?
Applications for Development of a Three-Component Iron-Catalyzed Difluoromethylation Reaction are due 2029-05-31 (open). Because deadlines can change, verify the date with the funder, NIGMS - National Institute of General Medical Sciences, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Development of a Three-Component Iron-Catalyzed Difluoromethylation Reaction?
To apply for Development of a Three-Component Iron-Catalyzed Difluoromethylation Reaction, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIGMS - National Institute of General Medical Sciences.